Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ANET vs GSK✓SelectedUSD · GSKANET vs GSK performance historyLatest closeAs of-11.59%11/20
Stock and ETF performance explorer

ANET vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+423.2%
GSK return
+40.7%
Excess return
+382.5%
Maximum drawdown
-50.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-11.6%-0.1%-11.5%-11.6%
7D-15.0%-5.3%-9.7%-15.1%
30D-9.1%-3.7%-5.4%-9.1%
3M-8.8%-7.3%-1.5%-8.7%
6M+19.3%-4.2%+23.6%+19.2%
YTD+27.9%+0.9%+27.1%+27.4%
1Y+40.2%+7.3%+32.9%+39.0%
3Y+211.4%+52.7%+158.6%+194.6%
All+423.2%+40.7%+382.5%+368.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling